Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors

• Main Authors: Nunghathai Sawasdee, Methichit Wattanapanitch, Nontaphat Thongsin, Nattaporn Phanthaphol, Chutipa Chiawpanit, Chanitra Thuwajit, Pa Thai Yenchitsomanus, Aussara Panya
• Other Authors: Siriraj Hospital
• Format: Article
• Published: 2022
• Subjects: Biochemistry, Genetics and Molecular Biology
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/73408
• Institution: Mahidol University

Breast cancer (BC) is the most common cancer in women. Although standard treatments are successful in patients with BC diagnosed at an early stage, an alternative treatment is required for patients with advanced-stage disease who do not respond to these treatments. The concept of using chemotherapy...